US FDA approves first mRNA flu shot from Moderna - Reuters

The U.S. Food and Drug Administration has granted approval for Moderna's influenza vaccine, marking the first mRNA-based flu shot to receive regulatory clearance in the United States. This milestone represents the expansion of mRNA technology beyond COVID-19 vaccines into seasonal flu prevention.